Atossa Genetics Inc. (ATOS) Social Stream



Atossa Genetics Inc. (ATOS): $1.13

0.02 (+1.80%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

C

Add ATOS to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#134 of 347

in industry

Featured Post From StockTwits About ATOS

$ATOS - Atossa Therapeutics DD , updates on their AT-301 / AT-H201 COVID and Endoxifen breast cancer treatments.

It’s time to discuss Atossa Therapeutics again without so much negativity. I know there was the nonsense about a short squeeze/gamma squeeze, but this is a longer term hold. Now that the dust has settled, I am revisiting this play. Especially now with all the variants this could be a covid play as well...

New Positions Reported:

Group One Trade – 1,644,488 Shares

Nuveen Asset Management, - 1,097,131 Shares

Millennium Management 1,666,911 Shares

Bank of Nova Scotia – 348,698 Shares

Increased Positions Reported:

Northern Trust Corp - 1,1231,852 Shares

Vanguard Group Inc – 5,762,626 Shares

Geode Capital Management – 1,968,745 Shares

BlackRock Inc – 8.954,293 Shares

Bank of New York Mellon Corp – 465,572 Shares

Let’s talk about the timeline on Phase 3 for Endoxifen. FDA 505(b)(2) may bring Endoxifen to market without the need of Phase 3.

https://www.reddit.com/r/pennystocks/comments/p5s2pq/atossa_therapeutics_dd_updates_on_their_at301/
rigpig, published August 17, 2021

Loading social stream, please wait...


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!